Tislelizumab Combined With Chemotherapy Versus Chemotherapy Alone in Recurrent or Metastatic Nasopharyngeal Cancer (NPC)

Clinical trial NCT03924986 · COMPLETED

Trial details

NCT number: NCT03924986
Sponsor: BeiGene
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Recurrent or Metastatic Nasopharyngeal Cancer

Start date: 2019-03-27
Primary completion: 2021-03-26
Enrollment: 263

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.